Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-19-000184

Chief Medical Officer and SVP gave up 4,823 shares (to pay taxes)

  • Chief Medical Officer and SVP acquired 16,269 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stromatt Scott C Chief Medical Officer and SVP 2019-03-01 Option exercise +16,269 221,006 D
Stromatt Scott C Chief Medical Officer and SVP 2019-03-01 Shares withheld for taxes −4,823 $1.57 $7,572 216,183 D
Derivatives
Stromatt Scott C Chief Medical Officer and SVP 2019-02-28 Grant or award · Stock Option (right to buy) +67,400 67,400 D
Stromatt Scott C Chief Medical Officer and SVP 2019-03-01 Option exercise · Restricted Stock Unit −16,269 0 D
Loading xslF345X03/stromatt.xml…